Courtesy: DW
London: German vaccine-maker Curevac has said that its COVID-19 vaccine CVnCoV can remain stable for at least 3 months at 5 degrees Celsius. This would make it easier to distribute with normal refrigeration containers, unlike Pfizer’s vaccine which reportedly requires -70 degrees Celsius.
However, Curevac is not one of the frontrunners in the vaccine race. It hopes to start phase 3 trials by end of the this year. Frontrunners such as Moderna, Pfizer, AstraZeneca and Johnson & Johnson are ahead in the race with some ready to launch the vaccine in a couple of months.
Mumbai: Lalita D'Silva, Taimur's former nanny, expressed her disbelief over the news of the seven-year-old…
Pune: As many as 59 people have been diagnosed with Guillain-Barre Syndrome (GBS), a rare…
Baripada: Forest officials on Thursday rescued a fishing cat was rescued from a canal near…
Balasore: Excise officials have seized brown sugar worth more than Rs 7 lakh and arrested…
Lahore: In a bid to tighten control over social media, Pakistan is set to bring…
Bhubaneswar: The BJD has taken a strong exception to the statement of Odisha Assembly Speaker…
This website uses cookies.
